Inaugural symposium draws diverse science, underrepresented voices to MIT
Catalyst Symposium is part of an effort to bring outstanding postdocs from underrepresented backgrounds in science to engage with MIT community members.
Catalyst Symposium is part of an effort to bring outstanding postdocs from underrepresented backgrounds in science to engage with MIT community members.
Omer Yilmaz’s work on how diet influences intestinal stem cells could lead to new ways to treat or prevent gastrointestinal cancers.
Award honors researchers who “have had a direct impact on business and industry through their scientific achievements and contributions.”
The chemical engineer is honored for her work designing polymers and nanomaterials with wide-ranging applications in medicine and energy.
A cancer vaccine combining checkpoint blockade therapy and a STING-activating drug eliminates tumors and prevents recurrence in mice.
With the new method, scientists can explore many cancer mutations whose roles are unknown, helping them develop new drugs that target those mutations.
Ahead of the Institute’s presidential inauguration, panelists describe advances in their research and how these discoveries are being deployed to benefit the public.
Professor Emerita Nancy Hopkins and journalist Kate Zernike discuss the past, present, and future of women at MIT and beyond.
The new diagnostic, which is based on analysis of urine samples, could also be designed to reveal whether a tumor has metastasized.
The technology, which mimics the body’s natural clotting process, could help keep severely injured people alive until they are treated at a hospital.
The printer generates vaccine-filled microneedle patches that can be stored long-term at room temperature and applied to the skin.
In a new study, immunostimulatory drugs slowed tumor growth without producing systemic inflammation.
With sustainability in mind, MIT’s EHS Lab Plastics Recycling Program gathers clean plastics from 212 MIT labs, recycling some 280 pounds per week.
The global health care company Sanofi is providing $25 million to advance RNA research.
Using these RNA-delivery particles, researchers hope to develop new treatments for cystic fibrosis and other lung diseases.